Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 188
Selected: 0
NCT IDTitle
NCT00890617Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis
NCT05028374COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
NCT01022138Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
NCT00243048Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00030420Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT02470559Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
NCT01415089Tailored Web-Based Intervention for Cancer Patients and Family Caregivers
NCT00768118A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
NCT01656304Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
NCT04088786Phase I Trial HIPEC With Nal-irinotecan
NCT02521090EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
NCT00238329PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
NCT00942422Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
NCT00056004Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
NCT01504711Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
NCT01270880Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT00369109Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT04479267Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
NCT05325281CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
NCT01534143High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
NCT02960594hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
NCT07222306Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
NCT00002923KRN5500 in Treating Patients With Metastatic Solid Tumors
NCT02906241PACCT: Partnering Around Cancer Clinical Trials
NCT05556473F-Tryptophan PET/CT in Human Cancers
NCT00003936Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT01728259First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
NCT02819024Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
NCT02269267The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT03454529The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
NCT00960427Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
NCT00003171Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
NCT02472275PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
NCT01609816Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
NCT05903092MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00503841Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
NCT00004003Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT04237584A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients
NCT02058706LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
NCT02568449Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
NCT00002656Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00120029Peer Counseling for Weight Loss
NCT03684005MyPatientPal: An App to Help Patients Manage Their Cancer Care
NCT07227831A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT01958372Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT00899665Proteases in Patients With Prostate Cancer That Has Spread to the Bone
NCT04037462Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy